Chronic Lymphocytic Leukemia

被引:20
作者
Shanshal, Mohammed [1 ]
Haddad, Rami Y. [2 ]
机构
[1] Rosalind Franklin Univ Med & Sci, Dept Med, Chicago Med Sch, N Chicago, IL 60064 USA
[2] Rosalind Franklin Univ Med & Sci, Div Hematol Oncol, Chicago Med Sch, Captain James A Lovell Fed Hlth Care Ctr, N Chicago, IL USA
来源
DM DISEASE-A-MONTH | 2012年 / 58卷 / 04期
关键词
FLUDARABINE; RITUXIMAB; CANCER; CYCLOPHOSPHAMIDE; OFATUMUMAB; SURVIVAL; DISEASE;
D O I
10.1016/j.disamonth.2012.01.009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:153 / 167
页数:15
相关论文
共 26 条
[11]   Phase III Randomized Study of Bendamustine Compared With Chlorambucil in Previously Untreated Patients With Chronic Lymphocytic Leukemia [J].
Knauf, Wolfgang U. ;
Lissichkov, Toshko ;
Aldaoud, Ali ;
Liberati, Anna ;
Loscertales, Javier ;
Herbrecht, Raoul ;
Juliusson, Gunnar ;
Postner, Gerhard ;
Gercheva, Liana ;
Goranov, Stefan ;
Becker, Martin ;
Fricke, Hans-Joerg ;
Huguet, Francoise ;
Del Giudice, Ilaria ;
Klein, Peter ;
Tremmel, Lothar ;
Merkle, Karlheinz ;
Montillo, Marco .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (26) :4378-4384
[12]   US Food and Drug Administration Approval: Ofatumumab for the Treatment of Patients with Chronic Lymphocytic Leukemia Refractory to Fludarabine and Alemtuzumab [J].
Lemery, Steven J. ;
Zhang, Jenny ;
Rothmann, Mark D. ;
Yang, Jun ;
Earp, Justin ;
Zhao, Hong ;
McDougal, Andrew ;
Pilaro, Anne ;
Chiang, Raymond ;
Gootenberg, Joseph E. ;
Keegan, Patricia ;
Pazdur, Richard .
CLINICAL CANCER RESEARCH, 2010, 16 (17) :4331-4338
[13]  
Linet MS, 2006, JF CANC EPIDEMIOLOGY, P841
[14]   Immunomodulatory drugs in chronic lymphocytic leukemia: A new treatment paradigm [J].
Molica, Stefano .
LEUKEMIA & LYMPHOMA, 2007, 48 (05) :866-869
[15]  
Montillo M, 2005, HAEMATOLOGICA, V90, P391
[16]  
Morris MJ, 2002, CLIN CANCER RES, V8, P679
[17]   GLOMERULONEPHRITIS IN CHRONIC LYMPHOCYTIC-LEUKEMIA AND RELATED B-CELL LYMPHOMAS [J].
MOULIN, B ;
RONCO, PM ;
MOUGENOT, B ;
FRANCOIS, A ;
FILLASTRE, JP ;
MIGNON, F .
KIDNEY INTERNATIONAL, 1992, 42 (01) :127-135
[18]  
NCCN, 2011, NCCN CLIN PRACT GUID, V2
[19]   Relative value of ZAP-70, CD38, and immunoglobulin mutation status in predicting aggressive disease in chronic lymphocytic leukemia [J].
Rassenti, Laura Z. ;
Jain, Sonia ;
Keating, Michael J. ;
Wierda, William G. ;
Grever, Michael R. ;
Byrd, John C. ;
Kay, Neil E. ;
Brown, Jennifer R. ;
Gribben, John G. ;
Neuberg, Donna S. ;
He, Feng ;
Greaves, Andrew W. ;
Rai, Kanti R. ;
Kipps, Thomas J. .
BLOOD, 2008, 112 (05) :1923-1930
[20]   Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia [J].
Rawstron, Andy C. ;
Bennett, Fiona L. ;
O'Connor, Sheila J. M. ;
Kwok, Marwan ;
Fenton, James A. L. ;
Plummer, Marieth ;
de Tute, Ruth ;
Owen, Roger G. ;
Richards, Stephen J. ;
Jack, Andrew S. ;
Hillmen, Peter .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (06) :575-583